Dragonfly Opstar
Device Vascular
PDI 05415067031129
General payments
$1,465,546
Research payments
$1,442,296
Through program year 2025, $1,465,546 in general payments and $1,442,296 in research payments were reported against Dragonfly Opstar (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $261,400 | 1,616 |
| 2025 | Research | $159,446 | 52 |
| 2024 | General | $316,904 | 1,477 |
| 2024 | Research | $77,659 | 21 |
| 2023 | General | $329,449 | 1,460 |
| 2023 | Research | $544,467 | 106 |
| 2022 | General | $553,794 | 2,019 |
| 2022 | Research | $660,724 | 313 |
| 2021 | General | $4,000 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,573 general · 492 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.